The AI landscape doesn't move in one direction — it lurches. Some techniques leap from experiment to table stakes in a single quarter; others stall against regulatory walls, technical ceilings, or organisational inertia that no amount of hype can dislodge. Knowing which is which is the hard part. The State of Play cuts through the noise with a rigorously maintained index of AI techniques across every major business domain — classified by maturity, evidenced by real-world adoption, and updated daily so you always know where you stand relative to the field. Stop guessing. Start knowing.
A daily newsletter distilling the past two weeks of movement in a domain or two — delivered to your inbox while the index updates in the background.
Each dot marks the weighted maturity of practices within a domain — hover for a brief summary, click for more detail
AI systems that make autonomous accept/reject decisions on manufactured items without human review. Includes confidence-gated auto-rejection and borderline case escalation; distinct from defect detection which flags issues for human review rather than making final decisions.
AI-driven autonomous reject/pass decisions in manufacturing quality inspection have crossed from experimental to proven -- the tooling is GA, the ROI is documented, and the question for most high-volume manufacturers is implementation, not feasibility. Unlike defect detection systems that flag anomalies for human review, these systems make final disposition calls: parts are accepted or rejected without an operator in the loop, governed by confidence thresholds and escalation logic for borderline cases. The business case is strong, with documented payback periods under two years and scrap-rate reductions of 20-30% across pharma, automotive, semiconductors, and electronics. Yet the label "autonomous" overstates current practice. Three-quarters of manufacturers still keep humans central to final decisions, and most production deployments use confidence-gated architectures that escalate uncertain cases rather than ruling on them. The gap between vendor marketing and shop-floor reality defines this practice's tension: mature enough that proven tooling and playbooks exist, but adoption depth remains uneven, constrained by data quality, legacy integration, and unresolved liability questions around AI-driven disposition in regulated sectors.
Cognex and Keyence dominate the vendor ecosystem with roughly 50% combined market share, shipping deep-learning platforms with autonomous decision capability. Cognex Q1 2026 earnings confirmed 24% YoY revenue growth with new In-Sight 6900 (NVIDIA-powered) and In-Sight 3900 (Qualcomm-embedded) platforms as strategic growth drivers, signaling continued vendor investment in edge-based autonomous inspection. A tier of agile competitors (Jidoka, SwitchOn DeepInspect, Visionify) has emerged with faster deployment cycles (8-14 months payback, <3 month setup) and meaningful traction with mid-market manufacturers. Major brands including Unilever, P&G, Bosch, Denso, Hyundai, and Tata Electronics have deployed autonomous inspection at scale. Schneider Electric scaled autonomous quality systems to nearly 100 smart factories with sub-two-year ROI; individual deployments achieved compelling outcomes: furniture manufacturer reduced defect rates from 15% to zero with 300% first-year ROI; FMCG manufacturer prevented $12M product recall with 100% detection accuracy in 4-week deployment; automotive OEM deployed fully autonomous inspect-and-act robotic systems with deterministic reject/pass decisions.
Yet adoption depth remains constrained by a systematic implementation gap. A survey of 520 manufacturing leaders found 94% using some form of AI and 52% applying it to quality -- yet only 7% have AI embedded in core processes. Field evidence from integrators reports 77% of AI vision implementations stall at pilot stage rather than progressing to full production deployment across shifts and plants. Barriers persist: data quality (54% of industrial professionals cite), legacy system integration (48%), and trust in autonomous decisions (43%). AOI systems remain vulnerable to environmental degradation -- lighting alone reduces accuracy up to 70%; training data brittleness leads to high false positives under production variability; PLC/SCADA integration gaps cause systems to operate blind to upstream process changes. The EU Product Liability Directive (effective December 2026) expands vendor liability for AI-driven systems, creating regulatory headwinds in pharma and automotive sectors where disposition errors carry outsized consequences. Market projection remains robust ($39.6B autonomous inspection market by 2032, 11.5% CAGR), but operational readiness barriers prevent the majority of ambitious deployments from reaching sustainable production scale.
— Critical assessment: 77% of AI vision implementations stall at pilot stage; identifies lighting degradation, training data brittleness, and PLC integration gaps as systematic barriers.
— Cognex Q1 2026 revenue $268M (+24% YoY), 113% EPS growth with CEO citing new In-Sight 6900 and 3900 autonomous platforms as strategic growth drivers.
— Cognex GA launch of In-Sight 3900 with edge-based autonomous inspection, 4X faster processing, PC-free operation, and real-world Fuji Seal packaging deployment.
— Furniture manufacturer deployed autonomous defect detection reducing defect rate from 15% to zero, cutting inspection time 80%, achieving 300% ROI with 4-month payback.
— US automotive OEM deployed fully autonomous inspect-and-act system using three-stage robotic autonomy (detection, marking, physical removal) for defective parts.
— FMCG manufacturer deployed multi-modal autonomous inspection preventing $12M product recall with 100% detection accuracy and 4-week deployment timeline.
— Critical technical assessment distinguishing genuine deep learning from rule-based systems; deep learning reduces changeover costs 60-80% and achieves setup in 5 days vs. 3-6 weeks.
— Comprehensive technical guide for FDA 21 CFR Part 11 and EU GMP Annex 11 compliant autonomous AI inspection (CNN defect classification); addresses regulatory constraints for autonomous decisions in regulated sectors.